BioRestorative Therapies, Inc.
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
BRTX | US
Overview
Corporate Details
- ISIN(s):
- US0906556065
- LEI:
- Country:
- United States of America
- Address:
- 40 MARCUS DRIVE, 11747 MELVILLE
- Website:
- https://www.biorestorative.com/
Description
BioRestorative Therapies, Inc. is a clinical-stage biotechnology company focused on developing regenerative medicine products and cell-based therapies. The company utilizes adult stem cells to address unmet medical needs, primarily in degenerative disc disease and metabolic disorders. Its lead clinical program, BRTX-100, is an autologous stem cell therapy for chronic lumbar disc disease currently in a Phase 2 clinical trial. Another development program, ThermoStem, uses brown adipose-derived stem cells to target metabolic conditions. In addition to its therapeutic pipeline, the company has a BioCosmeceutical platform that develops biologics based on secretome technology, including exosomes and growth factors, for aesthetic medicine applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioRestorative Therapies, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioRestorative Therapies, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioRestorative Therapies, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
